Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-036252
Filing Date
2025-03-10
Accepted
2025-03-10 16:05:30
Documents
97
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K okur-20241231.htm   iXBRL 10-K 3872803
2 EX-4.2 okur-ex4_2.htm EX-4.2 67737
3 EX-19 okur-ex19.htm EX-19 128521
4 EX-21.1 okur-ex21_1.htm EX-21.1 5649
5 EX-23.1 okur-ex23_1.htm EX-23.1 3594
6 EX-31.1 okur-ex31_1.htm EX-31.1 19468
7 EX-31.2 okur-ex31_2.htm EX-31.2 19591
8 EX-32.1 okur-ex32_1.htm EX-32.1 17557
9 EX-97 okur-ex97.htm EX-97 52331
10 GRAPHIC img79528723_0.jpg GRAPHIC 458499
11 GRAPHIC img79528723_1.jpg GRAPHIC 611593
12 GRAPHIC img79528723_2.jpg GRAPHIC 118029
13 GRAPHIC img79528723_3.jpg GRAPHIC 107874
14 GRAPHIC img79528723_4.jpg GRAPHIC 75231
15 GRAPHIC img79528723_5.jpg GRAPHIC 649137
16 GRAPHIC img79528723_6.jpg GRAPHIC 1035305
  Complete submission text file 0000950170-25-036252.txt   18920824

Data Files

Seq Description Document Type Size
17 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT okur-20241231.xsd EX-101.SCH 1639529
100 EXTRACTED XBRL INSTANCE DOCUMENT okur-20241231_htm.xml XML 1258800
Mailing Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301
Business Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301 (720) 307-2892
OnKure Therapeutics, Inc. (Filer) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40315 | Film No.: 25723670
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)